Filing Details
- Accession Number:
- 0001127602-14-014431
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-10 17:50:52
- Reporting Period:
- 2014-04-10
- Filing Date:
- 2014-04-10
- Accepted Time:
- 2014-04-10 17:50:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-04-10 | 3,833 | $34.56 | 3,973 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-10 | 3,833 | $96.21 | 140 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-04-10 | 5,233 | $30.75 | 5,373 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-10 | 600 | $95.29 | 4,773 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-04-10 | 3,833 | $96.11 | 940 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-04-10 | 800 | $97.08 | 140 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2014-04-10 | 3,833 | $0.00 | 3,833 | $34.56 |
Common Stock | Stock Options | Disposition | 2014-04-10 | 5,233 | $0.00 | 5,233 | $30.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
341,163 | 2005-12-30 | 2015-12-30 | No | 4 | M | Direct |
743,069 | 2009-12-26 | 2017-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 533,094 | Indirect | By Trusts |
Footnotes
- This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- This transaction was executed in multiple trades at prices ranging from $96.00 to $96.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $94.71 to $95.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $95.71 to $96.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $96.72 to $97.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.